Pfizer seeks UK approval for use of Covid vaccine in children aged 12 to 15
Branded Comirnaty, Pfizer's vaccine is subject to an EU review for children 12 to 15 years old, with approval expected at the end of May. The vaccine, which delivers instructions to the human body to build immunity against Covid-19, is also being tested in children aged 2 to 11. Data on that trial is expected in September, Pfizer said. Britain's vaccination campaign has been highly successful, with 54 million vaccines administered to more than 35.5 million people. Only adults and the clinically vulnerable have been offered inoculation by the National Health Service. As under-12s are less susc...